Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Histamine H3 receptor | Starlite/ChEMBL | References |
Homo sapiens | histamine receptor H2 | Starlite/ChEMBL | References |
Homo sapiens | histamine receptor H1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | amine GPCR | Get druggable targets OG5_128924 | All targets in OG5_128924 |
Schistosoma japonicum | ko:K04135 adrenergic receptor, alpha 1a, putative | Get druggable targets OG5_128924 | All targets in OG5_128924 |
Schistosoma japonicum | Alpha-1D adrenergic receptor, putative | Get druggable targets OG5_128924 | All targets in OG5_128924 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Histamine H3 receptor | 445 aa | 384 aa | 22.4 % |
Brugia malayi | hypothetical protein | histamine receptor H2 | 397 aa | 333 aa | 23.1 % |
Echinococcus granulosus | biogenic amine 5HT receptor | Histamine H3 receptor | 445 aa | 405 aa | 25.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1244 | 1 | 1 |
Onchocerca volvulus | 0.1244 | 1 | 1 | |
Schistosoma mansoni | brg-1 associated factor | 0.1244 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.1244 | 1 | 1 |
Chlamydia trachomatis | DNA topoisomerase I | 0.1244 | 1 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.1244 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1244 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1244 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.1244 | 1 | 1 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.0443 | 0.226 | 0.226 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.1244 | 1 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.1244 | 1 | 1 |
Echinococcus granulosus | tumor protein p63 | 0.0679 | 0.4544 | 0.2951 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.1244 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0443 | 0.226 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0443 | 0.226 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0443 | 0.226 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.1244 | 1 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.1244 | 1 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.1244 | 1 | 1 |
Schistosoma mansoni | fusion | 0.0443 | 0.226 | 0.226 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.1244 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.1244 | 1 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1244 | 1 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.1244 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1244 | 1 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0443 | 0.226 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.1244 | 1 | 1 |
Schistosoma mansoni | RNA binding protein | 0.0443 | 0.226 | 0.226 |
Leishmania major | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0443 | 0.226 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0443 | 0.226 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.1244 | 1 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0443 | 0.226 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0443 | 0.226 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1244 | 1 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0443 | 0.226 | 0.226 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0443 | 0.226 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0443 | 0.226 | 0.226 |
Schistosoma mansoni | hypothetical protein | 0.1244 | 1 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0679 | 0.4544 | 0.2951 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0443 | 0.226 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 4.2 nM | Binding affinity against rat histamine H3 receptor | ChEMBL. | 12372500 |
Ki (binding) | = 4.2 nM | Binding affinity against rat histamine H3 receptor | ChEMBL. | 12372500 |
Ki (binding) | = 380 nM | Binding affinity to the human Histamine H2 receptor | ChEMBL. | 12372500 |
Ki (binding) | = 380 nM | Binding affinity to the human Histamine H2 receptor | ChEMBL. | 12372500 |
Ki (binding) | = 5500 nM | Binding affinity to the human Histamine H1 receptor | ChEMBL. | 12372500 |
Ki (binding) | = 5500 nM | Binding affinity to the human Histamine H1 receptor | ChEMBL. | 12372500 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.